# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Robyn Karnauskas downgrades Biomea Fusion (NASDAQ:BMEA) from Buy to Hold.
Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $90 to...
HC Wainwright & Co. analyst Joseph Pantginis maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price targe...